Loxapine Capsule
Product Images NDC 82804-051

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Loxapine (NDC 82804-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Loxapine-molec-structure (Loxapine Capsules Usp 1)

Loxapine-molec-structure (Loxapine Capsules Usp 1)
Chemical structure of Loxapine base, depicting the molecular framework including a chlorinated phenyl ring, a piperazine ring with a methyl group, and other characteristic atoms and bonds.*
FDA Label Image

82804-051-30 (Loxapine Capsules Usp 2)

82804-051-30 (Loxapine Capsules Usp 2)
Label for Loxapine 5 mg capsules by Proficient Rx LP, containing 30 capsules. Each capsule contains Loxapine Succinate, USP equivalent to 5 mg loxapine. The capsules are described as opaque, dark green with imprint "LANNETT" on the cap and "1394" on the body. Distributed by Lannett Company, Inc., Philadelphia, PA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.